Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus
- 15 June 2000
- Vol. 88 (12) , 2782-2786
- https://doi.org/10.1002/1097-0142(20000615)88:12<2782::aid-cncr17>3.0.co;2-k
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- FIGO staging of gynecologic cancerInternational Journal of Gynecology & Obstetrics, 1999
- The Impact of Adjuvant Radiotherapy on Carcinosarcoma of the UterusGynecologic Oncology, 1998
- Carcinosarcoma of the Uterus: A Clinicopathological Multicenter CTF StudyGynecologic Oncology, 1997
- Prognostic parameters for survival of patients with malignant mesenchymal tumors of the uterusCancer, 1996
- Prognostic factors in early‐stage uterine sarcoma: A gynecologic oncology group studyCancer, 1993
- Carcinosarcoma (Malignant Mixed Mesodermal Tumor) of the UterusInternational Journal of Gynecological Pathology, 1990
- Clinicopathologic analysis of uterine malignant mixed müllerian tumorsGynecologic Oncology, 1989
- Management of malignant, mixed mesodermal tumors of the uterusGynecologic Oncology, 1989
- Prognostic value of peritoneal washings in patients with malignant mixed müllerian tumors of the uterusAmerican Journal of Obstetrics and Gynecology, 1986
- MIXED MESODERMAL SARCOMA OF THE UTERUSAmerican Journal of Roentgenology, 1973